NCT01126892View on ClinicalTrials.gov

A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Nilotinib

Trial Locations (2)

Unknown

Hospital San José, Bogotá, Colombia, Bogotá

Banco Municipal de Sangre, Caracas

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY